BPC-157 vs Acetyl Hexapeptide-8
Side-by-side comparison of BPC-157 and Acetyl Hexapeptide-8: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
BPC-157
Acetyl Hexapeptide-8
BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a partial sequence of human gastric juice…
Lowest listed price: $34.99 across 15 listings
Full BPC-157 profileAcetyl Hexapeptide-8
Acetyl Hexapeptide-8 (INCI: Acetyl Hexapeptide-3 in older nomenclature, commercially known as Argireline) is a synthetic hexapeptide designed as a competitive inhibitor of the SNARE complex at the neuromuscular junction.…
Lowest listed price: $129.00 across 1 listing
Full Acetyl Hexapeptide-8 profileSide-by-side comparison
| Attribute | BPC-157 | Acetyl Hexapeptide-8 |
|---|---|---|
| Category | Injury, Repair & Recovery | Skin & Hair |
| Research Stage | Preclinical | Marketed topical cosmetic ingredient (INCI: Acetyl Hexapeptide-8 / Argireline). Supported by small human anti-wrinkle studies, including one randomized, placebo-controlled trial; no systemic or injectable clinical development. Not an FDA-approved drug. |
| Mechanism of Action | Nitric Oxide (NO) System Modulation BPC-157 exerts a central integrative effect through modulation of the nitric oxide system. Studies by Seiwerth et al. (2022) demonstrated that BPC-157 counteracts both NO-excess and NO-deficiency states, functioning as a… | Acetyl Hexapeptide-8 (Argireline) is patterned after the N-terminal domain of SNAP-25 and behaves as a competitive mimic of that protein during SNARE complex assembly. The SNARE complex (SNAP-25 + Syntaxin-1 + VAMP/synaptobrevin) is required for… |
| Half-Life | Short plasma half-life. The first formal preclinical ADME study reported an elimination half-life under ~30 minutes after IV/IM dosing in rats and dogs, with linear dose-proportional kinetics (PMID: 36588717); a 2026 biopharmaceutical review confirms this sub-30-minute plasma half-life and highlights a pharmacokinetic-pharmacodynamic disconnect, as biological effects persist for hours to days (PMID: 42198317). No full human pharmacokinetic study has been published; twice-daily dosing is empirical/community-standard rather than PK-derived. | Short (topical application, no systemic absorption at cosmetic doses) |
| Typical Dose Range | 200-500 mcg subcutaneous 1-2x daily (community protocols); 1-10 mcg/kg in animal studies | — |
| Dosing Frequency | Twice daily (AM and PM) for optimal serum levels; once daily acceptable | twice_daily |
| Administration | Subcutaneous, Oral, Intraperitoneal, Intravenous | Topical |
| Side Effects | Generally well-tolerated. Mild nausea or GI discomfort during initial use. Temporary increase in pain/inflammation at injury site (healing response). Rare: drowsiness, dizziness, mild headache. Very rare: transient changes in blood pressure. | — |
| Molecular Weight | 1419.5 g/mol (average); molecular formula C62H98N16O22 | 888.99 g/mol (average); molecular formula C34H60N14O12S |
| Common Vial Sizes | 5mg, 10mg | — |
Price History
7 data points- OF
- BM
- Half Nattys
- LB
- Ion Peptide
- BHG Labs
Price tracking
BPC-157: potential benefits
- Accelerated tendon and ligament healing with improved biomechanical strength in preclinical soft-tissue injury models (PMID: 30915550)
- Gastric and GI mucosal cytoprotection against ethanol-induced lesions, mediated in part by the nitric oxide system (PMID: 30279308)
- Healing of cysteamine-induced colitis and colon anastomosis in preclinical inflammatory bowel disease models (PMID: 24304574)
- Neuroprotection with dopaminergic and nitric oxide-system modulation in central nervous system injury models such as stroke and dopamine-receptor blockade (PMID: 34380875)
- Promotion of angiogenesis via VEGFR2 up-regulation, internalization, and VEGFR2-Akt-eNOS signaling in rat hind-limb ischemia and endothelial assays (PMID: 27847966)
- Tendon fibroblast outgrowth, cell survival, and migration through FAK-paxillin pathway activation (PMID: 21030672)
- Growth hormone receptor up-regulation in tendon fibroblasts, potentiating growth hormone's proliferative effect (PMID: 25415472)
- Nitric oxide-system interaction with endothelium protection, angiogenesis, and EGR-1-mediated growth-factor and collagen expression (PMID: 22300085)
Acetyl Hexapeptide-8: potential benefits
- Targets dynamic expression wrinkles - forehead, glabellar, and periorbital (crow's feet) lines
- Proposed to reduce facial neuromuscular signaling by destabilizing the ternary SNARE complex (acts as a SNAP-25 N-terminal mimic)
- A randomized, placebo-controlled human study reported ~49% subjective improvement in periorbital wrinkles vs 0% for placebo over 4 weeks (small evidence base) [PMID: 23417317]
- Marketed as a topical 'Botox alternative' - reversible mechanism, not a neurotoxin, with no botulinum-type systemic risk
- Supplied as a raw cosmetic-compounding powder for research/formulation use (verify purity via HPLC COA)
- Commonly combined with related peptides (e.g., Acetyl Octapeptide-3 / Snap-8) in anti-wrinkle formulations
Frequently asked
What's the difference between BPC-157 and Acetyl Hexapeptide-8?
BPC-157 is a injury, repair & recovery that nitric oxide (no) system modulation bpc-157 exerts a central integrative effect through modulation of the nitric oxide system. studies by seiwerth et al. (2022) demonstrated that…. Acetyl Hexapeptide-8 is a skin & hair that acetyl hexapeptide-8 (argireline) is patterned after the n-terminal domain of snap-25 and behaves as a competitive mimic of that protein during snare complex assembly. the snare…. The two differ in mechanism, half-life (Short plasma half-life. The first formal preclinical ADME study reported an elimination half-life under ~30 minutes after IV/IM dosing in rats and dogs, with linear dose-proportional kinetics (PMID: 36588717); a 2026 biopharmaceutical review confirms this sub-30-minute plasma half-life and highlights a pharmacokinetic-pharmacodynamic disconnect, as biological effects persist for hours to days (PMID: 42198317). No full human pharmacokinetic study has been published; twice-daily dosing is empirical/community-standard rather than PK-derived. vs Short (topical application, no systemic absorption at cosmetic doses)), and typical dose range.
Which has the longer half-life, BPC-157 or Acetyl Hexapeptide-8?
BPC-157 has a half-life of Short plasma half-life. The first formal preclinical ADME study reported an elimination half-life under ~30 minutes after IV/IM dosing in rats and dogs, with linear dose-proportional kinetics (PMID: 36588717); a 2026 biopharmaceutical review confirms this sub-30-minute plasma half-life and highlights a pharmacokinetic-pharmacodynamic disconnect, as biological effects persist for hours to days (PMID: 42198317). No full human pharmacokinetic study has been published; twice-daily dosing is empirical/community-standard rather than PK-derived.. Acetyl Hexapeptide-8 has a half-life of Short (topical application, no systemic absorption at cosmetic doses). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, BPC-157 or Acetyl Hexapeptide-8?
Lowest listed price on BodyHackGuide: BPC-157 from $34.99, Acetyl Hexapeptide-8 from $129.00. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack BPC-157 and Acetyl Hexapeptide-8?
Stacking depends on mechanism overlap, safety profile, and goals. BPC-157 and Acetyl Hexapeptide-8 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy BPC-157 or Acetyl Hexapeptide-8
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.